Shanthi Veerappapillai | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Shanthi Veerappapillai | Drug Discovery and Development | Best Researcher Award

Dr Shanthi Veerappapillai, Vellore Institute of Technology, India

Dr. Shanthi Veerappapillai is a distinguished Professor at VIT University, specializing in Bioinformatics and Computational Biology. With a Ph.D. from VIT, her research interests include computational protein analysis, drug resistance studies, and virtual screening, particularly focusing on infectious diseases like HIV and tuberculosis. She has led multiple funded research projects and published over 130 peer-reviewed articles. Dr. Veerappapillai has been recognized with awards like the Women Achiever Award for Sponsored Research Excellence (2020) and has supervised numerous Ph.D. graduates. Her dedication to education and research is also reflected in her active participation in conferences and professional societies. 👩‍🔬📚💻🌍

Publication Profile

Google Scholar

Education Qualification

Dr. Shanthi Veerappapillai holds a Ph.D. in Bioinformatics from VIT University, Tamil Nadu, India, and an M.Tech in Chemical Process and Design from SASTRA University, Tamil Nadu, India. She also earned a B.Tech in Chemical Engineering from EGS Pillai Engineering College, Bharathidasan University, Tamil Nadu, India. With a strong foundation in both chemical engineering and bioinformatics, Dr. Veerappapillai brings a multidisciplinary approach to her research and academic work. Her diverse academic background equips her with the expertise to bridge the gap between technology and biology, contributing to advancements in various scientific fields. 🧬⚙️🎓

Leadership in Research

Dr. Shanthi Veerappapillai is a dedicated scientist with extensive leadership experience as Principal Investigator (PI) in multiple prominent projects. Her research spans critical areas such as drug repurposing strategies and cancer research, showcasing her expertise in advancing both medical and computational biology. Through her work, she has contributed significantly to the development of innovative therapeutic approaches, emphasizing her commitment to enhancing healthcare and medical research. Her ability to lead and collaborate on large-scale projects underscores her impact in the field, making her a valuable asset in shaping the future of medical science and computational biology. 🧬🔬💊

Mentorship and Teaching

Dr. Shanthi Veerappapillai is a distinguished academic with vast experience in supervising successful Ph.D. candidates and teaching specialized subjects in biotechnology and bioinformatics. Her dedication to fostering academic development is evident in her role as a mentor to future researchers. With a passion for guiding students through advanced research topics, she has contributed significantly to shaping the next generation of experts in her field. Her work in biotechnology and bioinformatics continues to inspire students, encouraging innovation and critical thinking in these dynamic disciplines. 👩‍🔬📚🎓🔬👩‍💻

Community Engagement

Dr. Shanthi Veerappapillai is a dedicated academician who has made significant contributions to the scientific community through her active involvement in organizing conferences and workshops. As a member of various professional bodies, Dr. Veerappapillai continuously strengthens her presence in the academic world, sharing her expertise and collaborating with fellow researchers. Her commitment to advancing knowledge and fostering professional connections has had a lasting impact on her field. With a focus on promoting growth in the academic and scientific community, Dr. Veerappapillai’s efforts continue to inspire others. 🌍🧑‍🏫📚

Awards and Achievement

Dr. Shanthi Veerappapillai is a distinguished researcher with 131 peer-reviewed journal articles and an H-index of 14. She received the Best Chapter Award from BRSI-VIT for her exceptional contributions in 2023. She was honored with the Women Achiever Award for Sponsored Research Excellence in 2020 and has been a Research Fellow at INTI International University, Malaysia since June 2023. Dr. Veerappapillai’s academic journey includes producing 100% results in Chemical Engineering Thermodynamics courses and securing university ranks and prizes for academic excellence. She has also received several accolades, including a Best Poster Presentation Award at VIT University. 🏆📚👩‍🔬🌟

Research Focus

Dr. V. Shanthi’s research primarily focuses on molecular simulation, bioinformatics, and computational approaches to drug discovery. She has explored mechanisms of drug resistance, particularly in influenza virus neuraminidase, using molecular simulations to understand oseltamivir resistance. Her work also spans polypharmacology, investigating therapeutic agents for non-small cell lung cancer, and the identification of potential inhibitors for various viruses like H5N1. Additionally, she has contributed to bioprocess industry applications, drug repurposing, and plant-based therapeutic compounds. Her research aims at enhancing drug design, discovering novel therapeutic agents, and understanding the molecular interactions that govern drug efficacy. 🔬💊🦠💡

Publication Top Notes

Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach

Current progress and future perspectives of polypharmacology: From the view of non-small cell lung cancer

Bioactive Amento flavone isolated from Cassia fistula L. leaves exhibits therapeutic efficacy

Application of heat exchangers in bioprocess industry: a review

Multi-dimensional screening strategy for drug repurposing with statistical framework—a new road to influenza drug discovery

Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach

Role of the cation-π interaction in therapeutic proteins: A comparative study with conventional stabilizing forces

 

 

 

Ayaz Ahmed | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Ayaz Ahmed | Drug Discovery and Development | Best Researcher Award

Dr Ayaz Ahmed, ICCBS – University of Karachi, Pakistan

Dr. Ayaz Ahmed 🧬🔬 is a Principal Investigator and Assistant Professor at the Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi, Pakistan. With a Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University, China, and an M.Sc. in Microbiology from the University of Karachi, his research focuses on microbial profiling, anti-biofilm agents, and infectious disease models. Dr. Ahmed has supervised numerous postgraduate students and received multiple international awards, including recognition from the American Society for Microbiology and Bill & Melinda Gates Foundation. He also leads funded projects on combating antibiotic-resistant pathogens. 🌟

Publication Profile

google scholar

Qualifications

Dr. Ayaz Ahmed holds a Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University, China (2012), and a Master’s in Microbiology from the University of Karachi, Pakistan (2006, First Division). 🧬🎓 His doctoral research focused on the “Microbial profiling of dental plaque/Biofilm from dental caries and periodontitis patients” and explored the effects of Lactobacillus species on S. mutans biofilm formation. 🦷🔬 With a strong academic foundation and research expertise in microbiology and molecular biology, Dr. Ayaz contributes significantly to the understanding of microbial interactions in dental health and disease. 🌟

Job Responsibilities

Dr. Ayaz Ahmed is a Principal Investigator at the Cell Biology Lab, where he oversees the Imaging Facility, maintaining high-end fluorescence and light microscopes. He supports students by assisting them in acquiring high-quality images for their theses and manuscripts. Dr. Ahmed also manages the National Animal Facility for Laboratory Animal Research and Care. He supervises routine animal house operations and collaborates with a veterinary doctor to maintain SPF rats, mice, and hamsters. He is responsible for establishing models for infectious diseases and memory deficits to evaluate the efficacy of natural compounds. Dr. Ahmed also conducts toxicological studies and trains students in ethical animal research practices. 🧬🔬🐁

Student Supervised

Dr. Ayaz Ahmed and his team of dedicated researchers have made significant strides in their exploration of innovative therapeutic strategies. Among the Ph.D. candidates, Zulfiqar Ahmed’s research on controlling salmonellosis through probiotics in poultry, Binte Zehra’s study on modulating the metastatic potential of NSCLC, and Jazib Shafiq’s investigation into gut dysbiosis and anxiety have all been awarded. Additionally, Afshan Shams, Yamina Usmani, and Shariqa Khuwaja are examining the potential of natural and synthetic compounds in combating oral cancer and other diseases. Several M. Phil. students are also contributing to research on antimicrobial resistance and cancer therapies. 🧪🔬🧫

Honors and Awards

Dr. Ayaz Ahmed has earned numerous accolades throughout his distinguished career. In 2024, he received the Award for Collaborative Scientific Achievement from the Institute of Food Science and Technology, Chinese Academy of Agriculture Science, Beijing. He also became an International Federation for Biosafety Association (IFBA) Certified Biological Waste Management Professional and Bio-risk Management Professional in 2023. Dr. Ahmed was selected as a Mentor for the ASM Future Leaders Mentoring Fellowship Program in 2023 and was awarded the Health Security Partner Grant by the Bill & Melinda Gates Foundation in 2021. He has also earned prestigious travel awards and fellowships, including the American Society for Microbiology ID Fellowship and the Science and Technology Talent Award. 🏅🌍🦠

Completed Projects

Dr. Ayaz Ahmed has led multiple impactful research projects focused on combating multidrug-resistant microorganisms and improving public health. His research on the effect of synthetic and natural compounds on biofilm formation was funded by the Higher Education Commission of Pakistan (HEC) under project # HEC No: PD-IPFP/HRD/HEC/ 2013/1182. He also contributed to projects such as Personal Protective Equipment for Sindh Poultry Vaccine Center (funded by CRDF Global, USA), and oral pathogens related to dental caries (funded by ICCBS). Notably, his work on antimicrobial-resistant water contaminants, funded by the U.S.-Pakistan Centers for Advanced Studies in Water, aims to improve water quality. He further advanced research on antimicrobial and antibiofilm agents targeting Acinetobacter baumannii and Klebsiella pneumonia with funding from HEC. 💧🔬🦠

Professional Experience

Dr. Ayaz Ahmed has had a distinguished career in academia and research. Since June 2017, he has been serving as an Assistant Professor at the International Center for Chemical and Biological Sciences, University of Karachi. Prior to this, he worked as a Senior Research Officer at the same institution from November 2013 to June 2017. Dr. Ahmed also pursued Post-Doctoral training in Behavioral Sciences at Hunan Drug Safety Evaluation in Changsha, China, from January 2016 to February 2017. His earlier roles include Assistant Professor on Interim Placement, Research Officer in Avian Influenza Vaccine Production, and a research intern in the National Internship Program. 🧪📚

Professional Membership

Dr. Ayaz Ahmed is an active member of several prestigious professional organizations, contributing significantly to the fields of microbiology and infectious diseases. His memberships include the American Society for Microbiology (ASM) 🦠, the Pakistan Biological Safety Association (PBSA) 🧫, and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 🌍. Additionally, he is a member of the American Association of Cancer Research (AACR) 🎗️ and the Medical Microbiology & Infectious Disease Society of Pakistan (MMIDSP) 🇵🇰. These memberships reflect his commitment to advancing research and innovation in microbiology, infectious diseases, and cancer research.

Research Focus

Dr. Ayaz Ayaz Ahmed research focus primarily revolves around microbiology, particularly in the fields of gut microbiota analysis, antimicrobial resistance, and biofilm formation. His studies often investigate the interactions between microorganisms and the human or animal host, such as comparing gut microbe profiles between healthy individuals and those with conditions like hyperthyroidism and liver cirrhosis. Additionally, Dr. Ahmed explores innovative therapeutic approaches, including the development of antimicrobial agents, such as nanoparticles conjugated with antibiotics to combat biofilm-forming pathogens like Klebsiella pneumoniae and Staphylococcus aureus. His work has significant implications for medical microbiology and the treatment of infectious diseases. 🦠🔬

Publication Top Notes

Gut microbe analysis between hyperthyroid and healthy individuals

Phylogenetic and biological characterization of Newcastle disease virus isolates from Pakistan

Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella pneumoniae

Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals

Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae

Effect of Lactobacillus species on Streptococcus mutans biofilm formation.

Comparison of oral microbiota in orthodontic patients and healthy individuals

Synthesis and Chemosensing of Nitrofurazone using Olive oil based Silver Nanoparticles (O-AgNPs)

Isolation of dihydrobenzofuran derivatives from ethnomedicinal species Polygonum barbatum as anticancer compounds

Ali Olad | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Ali Olad | Drug Delivery Systems | Best Researcher Award

Prof Ali Olad, University of Tabriz, Iran

Prof. Ali Olad is a distinguished researcher in applied chemistry, specializing in polymer composites, conducting polymers, and polymeric coatings. 🎓 He earned his Ph.D. in Applied Chemistry (2003) from the University of Tabriz, where he continues to teach courses on industrial chemistry, polymer nanocomposites, and coatings. 📚 His research focuses on nanocomposites, conducting polymers, corrosion resistance, and environmental pollutant detection. 🌱🧪 Prof. Olad has presented groundbreaking work globally, authored influential books, published high-impact papers, and holds patents on polyaniline nanostructures and advanced materials. 🏆💡 His innovations in hydrogels, fertilizers, and sensors reflect his commitment to sustainable and practical chemical solutions. 🌍✨

Publication Profile

Google Scholar

Educational Background

Prof. Ali Olad is a distinguished academic specializing in Applied Chemistry, with a focus on polymer composites, conducting polymers, and corrosion-resistant polymeric coatings. 🎓 He earned his Ph.D. in Applied Chemistry (Polymer Composites & Conducting Polymers) from the University of Tabriz, Iran, in 2003. 📘 Prior to this, he completed his M.Sc. in Applied Chemistry (Corrosion & Polymeric Coatings) in 1997 and his B.Sc. in Applied Chemistry in 1995, both from the same institution. 🔬 His expertise and academic achievements contribute significantly to advancements in materials science, fostering innovative research and practical applications in the field. 🌟

Experience

Prof. Ali Olad has a remarkable teaching career at the University of Tabriz, offering diverse courses across various academic levels. He has taught Conducting Polymers at the Ph.D. level (2006–2010) and Industrial Chemistry 2 at the B.Sc. level since 1997. Additionally, he lectured on Industrial Electrochemistry (2003–2017). Prof. Olad continues to teach Coatings and Adhesives (Ph.D.), Polymer Composites and Nanocomposites (M.Sc.), and Physical and Mechanical Properties of Polymers (M.Sc.) since 2010. His dedication to education and expertise in polymers, nanocomposites, and industrial chemistry have greatly contributed to the field. 🎓📚🧪✨

Research Interests

Prof. Ali Olad specializes in the fields of polymer composites and nanocomposites, focusing on their development and applications. His expertise extends to surface modification and polymer coatings, enhancing material performance. Additionally, he works on conducting polymers and blends, exploring their conductive properties. Prof. Olad’s research also delves into polymer hydrogels, investigating their potential in various biomedical and industrial applications. Furthermore, he studies corrosion and electrochemistry, aiming to improve material durability and sustainability. His contributions to these areas have led to advancements in materials science and engineering. 🌐🔬🧪💡🛠️

Research Focus

The individual behind these publications appears to have a research focus in materials science, environmental engineering, and nanocomposites, with particular attention to polymers, hydrogel systems, and waste treatment technologies. Their work spans a range of topics such as electrocoagulation for dye removal, slow-release fertilizers, and anti-corrosion coatings, with an emphasis on nanocomposite materials like clay-polymers, superabsorbent hydrogels, and conductive polymers. This person is also involved in environmental cleanup and water treatment, exploring methods to improve water quality by utilizing advanced materials and nanotechnology 🧪🌍💧🔬.

Publication Top Notes

Decolorization of basic dye solutions by electrocoagulation: An investigation of the effect of operational parameters

Slow-released NPK fertilizer encapsulated by NaAlg-g-poly (AA-co-AAm)/MMT superabsorbent nanocomposite

Anti-corrosive properties of polyaniline coating on iron

Slow-release NPK fertilizer encapsulated by carboxymethyl cellulose-based nanocomposite with the function of water retention in soil

Polymer-clay nanocomposites

Superabsorbent hydrogel made of NaAlg-g-poly (AA-co-AAm) and rice husk ash: Synthesis, characterization, and swelling kinetic studies

On the preparation and swelling properties of hydrogel nanocomposite based on Sodium alginate-g-Poly (acrylic acid-co-acrylamide)/Clinoptilolite and its …

Removal of chromium from aqueous solution using polyaniline–poly ethylene glycol composite

Optimization of electrocoagulation process for removal of an azo dye using response surface methodology and investigation on the occurrence of destructive side reactions

Preparation and anticorrosive properties of PANI/Na-MMT and PANI/O-MMT nanocomposites

The synergetic effect of bioactive ceramic and nanoclay on the properties of chitosan–gelatin/nanohydroxyapatite–montmorillonite scaffold for bone tissue engineering

 

 

 

 

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Mr Victor Ajayi, University of Medical sciences Ondo Nigeria, Nigeria

Mr. Oluwadamilola Victor Ajayi is a distinguished academic and researcher in human physiology 🧬, with a B.Tech, M.Sc., and M.Phil. from reputable institutions. His groundbreaking research focuses on anti-ulcerogenic and antioxidant effects, phytochemical profiling, and bioactive compounds’ therapeutic roles 🩺. With over a decade of teaching experience at UNIMED 🎓, he excels in curriculum development and research mentorship. A member of esteemed bodies like PSN and Physoc 🏅, Mr. Ajayi actively engages in advancing physiology through publications and conferences. His dedication to science and education makes him a standout contributor in his field 🌍.

Publication Profile

orcid

Educational Backgrounds

Victor Ajayi’s academic journey spans several prestigious institutions. He is currently pursuing an M.Phil in Human Physiology at the Federal University of Technology, Akure (FUTA), starting in November 2024. He previously attended the University of Medical Sciences (UNIMED), Ondo, from August 2022 to December 2024, and earned his M.Sc. in Human Physiology from the University of Ibadan in November 2018. Victor completed his B.Tech in Human Physiology at Ladoke Akintola University of Technology (LAUTECH) in November 2011. His earlier academic milestones include WAEC (2009) and NECO (2002). 🎓📚👨‍🎓

Work Experience

Victor Ajayi has a diverse work experience spanning various roles in academia and healthcare. He started with industrial training as a Technologist at Spring Specialist Hospital in 2010, followed by NYSC at Ondo State School of Nursing, where he taught Physiology and Anatomy. Victor later worked as a teacher and guest tutor at different institutions, including Integrity Nursery, Ondo State School of Nursing, and several colleges. At the University of Medical Sciences, he serves as an Assistant Lecturer, course coordinator, and level adviser, while also supervising graduate students. His contributions to Physiology education remain invaluable. 🏥📚👨‍🏫

Membership

Mr. Victor Ajayi D. is an active member of esteemed professional bodies such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc). Over the years, he has attended several notable conferences and workshops, including the 28th and 29th Scientific Conferences of PSN at the University of Ilorin in 2008 and 2009, and the 31st conference at Lagos State University in 2011. He also participated in workshops on pedagogy, effective communication, animal ethics, and integrated registration. His dedication to continued learning is evident in his certified seminar attendance, such as the Bioinformatics and Genomics course in October 2024. 📚🔬🧑‍🏫

Community and Professional Engagement

Mr. Victor Ajayi has consistently showcased remarkable leadership in professional communities. As a dedicated member of esteemed organizations such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc), he has made significant contributions to the advancement of his field. His active participation in numerous conferences and workshops underscores his commitment to continuous learning and staying at the forefront of his profession. Through these engagements, Mr. Ajayi has demonstrated a passion for professional growth and a commitment to fostering collaboration within the scientific community. His involvement continues to inspire and influence others in the field. 💼📚

Accolades and Recognition

Mr. Victor Ajayi has made significant contributions to research, education, and professional development, positioning him as a strong contender for the Best Researcher Award. Although his CV does not highlight specific prior awards, his innovative approaches to addressing physiological challenges and his commitment to advancing scientific knowledge demonstrate his potential. Additionally, his dedication to mentoring the next generation of researchers reflects his passion for nurturing talent and fostering academic growth. Mr. Ajayi’s work continues to inspire and impact the research community, showcasing his outstanding ability to drive change and innovation in his field. 🏆📚🔬

Research Focus

Mr. Victor Ajayi’s research focuses on the anti-inflammatory and anti-oxidative effects of pasteurized yoghurt in mitigating gastric ulceration induced by indomethacin in male Wistar rats. This study delves into gastrointestinal health and the potential therapeutic benefits of food-based interventions in inflammatory conditions. His work contributes to pharmacology, nutritional science, and biomedical research with an emphasis on how diet and natural substances can influence disease progression and provide alternative treatments. This aligns with the field of Pharmacological Toxicology and Gastroenterology, exploring the intersection of nutrition and pharmacology in disease management. 🧑‍⚕️🍽️💊

Publication Top Notes

Anti-inflammatory and anti-oxidative effect of pasterurised yoghurt in indomethacin induced gastric ulceration in male Wistar rats

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Dr Michael Swedberg, Swedberg Preclinical Partner, Sweden

Dr. Michael Swedberg is a distinguished pharmacologist with extensive expertise in safety pharmacology, CNS pharmacology, gastrointestinal pharmacology, and drug abuse assessment. He has held key leadership roles, including Associate Director at AstraZeneca and founder of Swedberg Preclinical Partner AB. His global impact includes contributions to regulatory compliance, developing novel animal models, and mentoring future researchers. With a Ph.D. in discrimination learning and postdoctoral training at NIDA, Dr. Swedberg has collaborated internationally and received numerous accolades for his innovative research and leadership. His career embodies excellence in pharmacology and preclinical drug discovery. 🌍💊🔬

Publication Profile

scopus

Education

Dr. Michael Swedberg is a distinguished academic and researcher, having earned his Ph.D. in 1985 from the University of Uppsala, Sweden. His doctoral dissertation focused on “A Model of Discrimination Learning with Interoceptive Stimuli.” He completed his postdoctoral fellowship at the National Institutes of Health (NIH), specializing in addiction research at the National Institute on Drug Abuse’s Preclinical Pharmacology Branch in Baltimore, Maryland (1985–1988). Additionally, Dr. Swedberg holds a Bachelor of Social Science (B.S.Sc.) from Uppsala University, with a comprehensive background in psychology, sociology, and law. 🧠📚🎓

Professional Appointments

Dr. Michael Swedberg has had an extensive and distinguished career in pharmacology and drug discovery. From 2014 to 2021, he was the Founder and CEO of Swedberg Preclinical Partner AB in Sweden. Prior to that, he was a Partner and Consultant at The Research Network (TRN) from 2014 to 2016. His earlier career includes key roles at AstraZeneca R&D, where he served as Associate Director in Safety Pharmacology and Preclinical Development. He also held senior leadership positions at Novo Nordisk and Ferrosan. Dr. Swedberg’s journey began as a Lecturer at Mälardalen University in 1981. 🧑‍🔬💉📚

Academic Service

Dr. Michael Swedberg has made significant contributions to the field of pharmacology and neuroscience through various roles. He served as a board member for the Department of Psychology at the University of Uppsala and the Faculty of Social Sciences from 1980 to 1985. His leadership extended to chairing the Council of Graduate Students. Recognized for his service, Dr. Swedberg received awards from the Drug Abuse Liability Ad Hoc Committee and for his work with the Lilly–Novo Nordisk Muscarinic Research Collaboration. He has also been a grant evaluator for the European Union and Poland’s National Centre for Research and Development. 🌍🔬🧠

Presentations

Dr. Michael Swedberg has made significant contributions to the field of drug safety and abuse liability assessment. His research, presented at multiple prestigious meetings, includes the role of drug discrimination studies in evaluating novel compounds’ abuse potential. Notably, his work at the Safety Pharmacology Society, American College of Toxicology, and the Swedish Pharmaceutical Congress has advanced methodologies like rat self-administration and drug discrimination for psychoactive effects. His work on the interaction between mGluR5 antagonists and benzodiazepines also stands out. Swedberg’s contributions to safety pharmacology have had a lasting impact on CNS drug development and regulatory guidelines. 🧠💊

Lecturing and teaching

Dr. Michael Swedberg has delivered extensive lectures and seminars on safety pharmacology, drug abuse, and CNS risk assessment. His contributions include lectures at the American College of Toxicology, Safety Pharmacology Society, and the European Congress of Toxicologic Pathology, focusing on drug dependence, abuse liability, and CNS safety. Additionally, Swedberg has provided in-depth training on the regulatory and industrial challenges in drug development at AstraZeneca and other global platforms. His teaching spans from the biomedical program at Karolinska Institute to the University of Uppsala, covering neuropharmacology, psychopharmacology, and drug addiction. His educational materials are widely respected in the field. 🧠📚💊

Academic Supervision

Dr. Michael Swedberg has mentored numerous students at various stages of their academic careers, including graduate, Ph.D., and postdoctoral researchers. He supervised students at Umeå University, University of Uppsala, and Karolinska Institute, guiding experimental work in fields such as cannabinoid tolerance, dopamine release, and nicotine’s effects on learning. His postdoctoral supervision included projects on visual and auditory discrimination in drug testing. Swedberg’s research has been supported by multiple prestigious grants, such as the Clas Groschinsky Memorial Foundation and the Swedish Medical Research Council. His contributions have significantly advanced brain and behavior research. 🎓🧠💡

Committee Service

Dr. Michael Swedberg held several key roles at AstraZeneca, including membership in the Safety Knowledge Group for CNS and leadership in CNS GLP Safety Pharmacology Harmonization. He was also a part of multiple committees, such as the AstraZeneca Expert Advisory Group on Abuse Liability and the Cross Company Abuse Liability Consortium. Dr. Swedberg contributed to international organizations like PhRMA and CPDD, focusing on drug abuse liability. He attended professional courses in safety pharmacology, project management, and leadership, further enhancing his expertise. Additionally, he completed a teaching course at Karolinska Institute, strengthening his academic influence. 🧠💊🎓

Research Focus

Dr. Michael Swedberg’s research focuses on the pharmacology of muscarinic receptors and their potential therapeutic applications, particularly in relation to neurological and psychiatric disorders. His work has delved into muscarinic receptor agonists, with significant contributions to the understanding of their antipsychotic and antinociceptive properties. Additionally, he has explored the role of nicotinic compounds and their reinforcing effects. His research has implications for treating conditions like schizophrenia, Alzheimer’s disease, and irritable bowel syndrome. 🧠🔬💊 His studies on receptor-ligand interactions and pharmacological profiles contribute to the development of novel drugs for various neurological and gastrointestinal conditions.

Publication Top Notes

Approaches for early identification of abuse potential liability

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

Drug Discrimination: Use in Preclinical Assessment of Abuse Liability

AZD9272 and AZD2066: Selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

Nazia chaudhary | Drug Repurposing | Young Scientist Award

Published on by Top Pharmaceutical

Nazia chaudhary | Drug Repurposing | Young Scientist Award

Dr Nazia chaudhary, ACTREC, TMC, India

Dr. Nazia Chaudhary is a distinguished cancer researcher 🧬 with a Ph.D. focused on pathways promoting tumorigenesis and therapy resistance upon Plakophilin 3 loss 🎗️. Her academic journey includes notable projects on protease-producing thermophiles 🌡️ and mitochondrial function ⚡. She co-holds patents on Lipocalin-2 antibodies 🧪 and has published extensively in high-impact journals 📚, including Redox Biology and FEBS Letters. A DST Inspire Faculty Fellow (2023) 🌟, she has received numerous awards, including the Vaishno Endowment Prize 🏆 and Mahindra Talent Scholarships 🎓. Dr. Chaudhary’s impactful work has been presented globally 🌍, including at Cold Spring Harbor Laboratory, New York.

Publication Profile

Orcid

Academic Project

Dr. Nazia Chaudhary is an accomplished researcher with a Ph.D. focused on the project “Characterization of pathways that promote tumorigenesis, radio, and chemo-resistance upon Plakophilin 3 loss.” 💡🧬 She worked on isolating and characterizing protease and antimicrobial-producing thermophiles from Ganeshpuri hot springs at St. Xavier’s College, Mumbai (Jan-Apr 2015). 🌋🔬 Additionally, she contributed to the external project “MKT1 Dependent Regulation of Mitochondrial Function” at Tata Institute of Fundamental Research (May-Aug 2014). 🧪⚙️ Her EXSP project involved isolating and screening thermophilic Actinomycetes for enzymes with industrial importance. 🔍🌡️ Dr. Chaudhary’s diverse research showcases her expertise in microbiology and biotechnology. 🌟

Conference Attended

Dr. Nazia Chaudhary has showcased her research on various esteemed platforms. She presented a poster titled “Screening of Thermophilic Actinomycetes Capable of Producing Enzymes of Industrial Importance” at the Shri Sajjan Gupta Memorial Trophy for Excellence in Biological Science, held on December 11, 2012, at G.N. Khalsa College. Another poster, “Increase in Lipocalin2 Expression Upon Plakophilin3 Loss Confers Chemo and Radioresistance to Tumor Cells,” was presented at the Environmental Mutagen Society of India (EMSI) conference in January 2018 at BARC, Mumbai, and at the prestigious Mechanisms & Models of Cancer meeting in August 2018 at Cold Spring Harbor Laboratory, New York. 🌟🔬📊

Awards and Honors

Dr. Nazia Chaudhary is a distinguished scholar with multiple accolades. She was awarded the prestigious DST Inspire Faculty Award in 2023 and recognized for her research on lipocalin 2 expression and chemo-radiotherapy resistance at the 14th Indo-Australian Biotechnology Conference. She served as a Board of Studies member for Sophia College’s Zoology Department (2018-2021). Throughout her academic journey, she earned various honors, including the Ramidevi Murlidhar Jalan Award 🏆, Saifee Education Aid Scholarship 🎓, and the Mahindra Search for Talent Scholarship 🌟. Her exceptional performance also earned her the Mrs. A. Varghese Prize 🥇 and several other prestigious scholarships and awards.

Patent

Dr. Nazia Chaudhary, along with Sorab N. Dalal, Manjula Das, Sujan K. Dhar, and Smitha P. K., contributed to the development of “Antibodies Against Lipocalin-2 and Use Thereof.” This groundbreaking research led to two key milestones. The first was the PCT application (PCT/IN2020/051068) with publication no. WO/2021/137254 on July 8, 2021. The second was the Indian patent (DBT Indian Patent no: 202021000274) granted on July 30, 2021, published in the Patent Office journal no. 31/2021. These innovations hold significant potential for medical advancements. 🧬💉🧪🔬

Research Focus

Dr. Nazia Chaudhary’s research focuses on the molecular mechanisms of cancer progression, therapy resistance, and invasion, particularly in triple-negative breast cancer (TNBC) and colorectal cancer. She investigates the role of Lipocalin 2 (LCN2) in regulating cellular processes like focal adhesion formation, actin glutathionylation, and ferroptosis inhibition, which are critical for tumor cell migration and resistance to treatment. Her work explores the interplay between signaling pathways, such as Src activation and glutathione metabolism, to uncover potential vulnerabilities in cancer cells. 🧬💥💉🧪🧫

Publication Top Notes

LCN2 promotes focal adhesion formation and invasion by stimulating Src activation

EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI

GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition

Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration.

The Role of Lipocalin 2 (LCN2) in Regulating Ferroptosis and Therapy Resistance

Ajaz Ahmad| Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Ajaz Ahmad | Drug Delivery Systems| Best Researcher Award

 King Saud University, Saudi Arabia

Author Profile

🎓Early Academic Pursuits 

Professor Ajaz Ahmad began his distinguished academic journey at the prestigious Hamdard University in New Delhi, India. He earned a Bachelor of Pharmacy (B.Pharm) in 2005, where he demonstrated an early inclination toward pharmaceutical sciences. Continuing his education at the same institution, he completed a Master of Pharmacy (M.Pharm) in 2007, refining his focus on drug delivery and molecular pharmacology. Driven by a passion for research, he pursued a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences, which he completed in 2011. His doctoral research laid the foundation for his expertise in drug discovery, pharmacokinetics, and the molecular mechanisms underpinning drug actions.

💼Professional Endeavors 

King Saud University, Saudi Arabia
Prof. Ahmad joined the College of Pharmacy at King Saud University in 2011 as an Assistant Professor in Clinical Pharmacy. Over the next decade, his contributions to research and teaching led to successive promotions—first as an Associate Professor in 2017 and then to his current role as Professor in Clinical Pharmacy in January 2024. At King Saud University, Prof. Ahmad’s role encompasses teaching advanced courses, mentoring postgraduate students, and conducting cutting-edge research in pharmacology and drug development.International Collaborations
Since 2015, Prof. Ahmad has served as a research collaborator with the Mayo Clinic, USA, a testament to his global reputation in pharmaceutical sciences. In 2013, he was appointed an Honorary Research Associate at the University of Hong Kong, further broadening his academic and professional network.Patents and Industry EngagementProf. Ahmad holds a U.S. patent (US20170231925A1) for treating neurovascular complications of diabetes mellitus. This innovation highlights his commitment to bridging the gap between research and practical healthcare applications.

🔬Contributions and Research Focus 

Prof. Ahmad’s research covers a broad spectrum of topics in pharmaceutical sciences, with particular focus areas including:Preclinical Drug Development: He has explored novel therapeutic agents, focusing on their efficacy, safety, and molecular mechanisms.Pharmacokinetics and Drug Metabolism: His work delves into the ADME (absorption, distribution, metabolism, and excretion) properties of drugs, optimizing formulations and dosing regimens.Bioanalytical Method Development: Prof. Ahmad designs and validates analytical methods for drug quantification, ensuring reproducibility and precision.Animal Models for Disease Research: He conducts in vivo studies simulating human diseases like cancer, diabetes, and cardiovascular disorders, with a focus on ethical handling and translational applications.Sepsis Research: Investigating biomarkers for early diagnosis and developing therapeutic strategies to combat sepsis.Vascular Pharmacology: Using myography techniques, he explores interventions for vascular diseases and evaluates novel therapeutic targets.

📖Notable Publications

Molecular insights into anti-Protozoal action of natural compounds against
  • Authors : Raish M; Ahmad A; MOHD SHAHNAWAZ KHAN; Kalam MA
  • Journal: biomolecular structure & dynamics
  • Year: 2023
A BOX-BEHNKEN DESIGN FOR OPTIMIZATION OF ULTRASOUND-ASSISTED EXTRACTION OF SINAPIC ACID FROM FRAGARIA ANANASSA
  • Authors : Mudassar Shahid; Ahmad A; Raish M; Bin Jardan YA; Alkharfy KM; Ahad A; Abul Kalam M; Ahmad Ansari M; Iqbal M; Ali N et al.
  • Journal: Pharmaceutical Society
  • Year: 2023
Sinapic acid alleviates 5-fluorouracil-induced nephrotoxicity in rats via Nrf2/HO-1 signalling.
  • Authors : Ahmad Ansari M; Shahid M; Ahmad SF; Ahmad A; Alanazi A; Malik A; Bin Jardan YA; Attia SM; Bakheet SA; Raish M
  • Journal: Pharmaceutical Sciences
  • Year: 2023
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
  • Authors : Zhang, M., Si, S.J., Dai, W.J., … Jin, F., Jiang, L.Q.
  • Journal: Pharmaceutical Society
  • Year: 2023
Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism.
  • Authors : Mohammad raish; Ahmad A; Mudassar Shahid; Yousef A Bin Jardan; Abdul Ahad; Dr Mohd Abul Kalam; Mushtaq Ahmad Ansari; Muzaffar Iqbal; Ali N; Alkharfy KM et al.
  • Journal:Molecules
  • Year: 2023

Dr. Rahul Reddy|Pharmacology|Excellence in Research

Published on by Top Pharmaceutical

Dr.RahulReddy|Pharmacology|Excellence in Research

Dr. Rahul Reddy at Lautoka Hospital ,Fiji

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Rahul Krishna Reddy, a passionate medical professional, laid the foundation of his academic journey at Lautoka Andhra Sangam Primary School, where he studied from 2000 to 2008. He then progressed to Natabua High School (2009–2013), excelling academically and developing a keen interest in the medical sciences. His educational journey gained international momentum when he pursued a Chinese language program (HSK Level 4) at Shandong University in 2013–2014. This preparatory phase was instrumental in equipping him with linguistic skills for his future studies in China.

Rahul enrolled at Dalian Medical University (2014–2019), where he earned his MBBS degree. His time at Dalian was marked by rigorous academic training and multiple internships, including at the First Affiliated Hospital of Dalian Medical University. This exposure to advanced medical systems honed his clinical skills and solidified his career in surgery and medicine.

Professional Endeavors 🩺

Rahul’s professional journey is a testament to his dedication and commitment to the healthcare field. His initial post-MBBS years were spent at renowned institutions, including the Colonial War Memorial Hospital and Lautoka Hospital, where he completed intensive internship programs (2019–2021). These internships provided him with hands-on experience in diverse medical and surgical disciplines.

From 2021 to 2022, he played a crucial role in Fiji’s fight against COVID-19 as part of the Nadroga/Navosa COVID Team, showcasing his adaptability and resilience in public health crises. Later, as a Medical Officer at Vatukarasa Health Center (2022–2023), Rahul delivered primary care services, demonstrating his ability to cater to the diverse medical needs of his community. Currently, he serves as a Surgical Registrar at Lautoka Hospital, focusing on complex surgical cases and contributing significantly to patient outcomes.

Contributions and Research Focus 🔬

Rahul has made significant strides in clinical research, focusing on improving healthcare outcomes in Fiji. His studies have explored critical areas such as burn injuries, appendicitis, and innovative surgical techniques. Notable publications include:

  • Burns Injury Characteristics and Outcomes at Lautoka Hospital, highlighting critical insights into managing burn patients in resource-limited settings.
  • Research on acute appendicitis outcomes, offering data-driven recommendations for improving surgical care in Fiji.
  • Pioneering work on laparoscopic radical prostatectomy, reflecting his interest in minimally invasive surgery.
  • Contributions to the understanding of rare cases like primary epithelioid hemangioendothelioma and seminal vesicle cystadenoma through internationally recognized publications.

Rahul’s commitment to research and evidence-based practice demonstrates his dedication to advancing medical science in the Pacific region.

Accolades and Recognition 🏆

Rahul’s work has been recognized both nationally and internationally. In 2024, he won the Outstanding Young Investigator Award at the Fiji Medical Association Research Conference. His impactful presentations at conferences, including the Diabetic Foot Symposium and the Pacific Islands Health Research Symposium, have established him as a thought leader in surgical and public health topics.

Rahul has also actively participated in workshops, such as the EMSB and Pain Management sessions, further enhancing his clinical expertise. His continued professional development reflects his commitment to lifelong learning.

Impact and Influence 🌏

Rahul’s influence extends beyond the operating room. As a healthcare provider in Fiji, he has been instrumental in improving patient care and mentoring junior medical staff. His research contributions address key regional healthcare challenges, ensuring evidence-based practices are integrated into daily medical routines.

During the COVID-19 pandemic, his involvement in the Nadroga/Navosa COVID Team was pivotal in managing the outbreak, reflecting his leadership skills and community dedication.

Legacy and Future Contributions 🚀

Rahul Krishna Reddy is poised to leave a lasting legacy in the medical field. His combination of clinical expertise, research acumen, and community service positions him as a trailblazer in Fijian healthcare. Looking ahead, Rahul envisions expanding his contributions to global medical research, particularly in surgical innovation and healthcare systems in resource-limited settings.

His unwavering dedication to improving healthcare outcomes and fostering medical education ensures his enduring impact. As he continues to grow professionally, Rahul exemplifies the values of compassion, innovation, and excellence in medicine.

Conclusion 🌟

From his early academic achievements to his current role as a Surgical Registrar, Rahul Krishna Reddy’s journey reflects an unwavering commitment to healthcare. His research and clinical endeavors are paving the way for improved medical practices in Fiji and beyond. Rahul’s accomplishments and aspirations set a high standard for the next generation of medical professionals, cementing his position as a leader in the field.

🎓Publication 

Laparoscopic excision of seminal vesicle cystadenoma

  • Authors   : Qi Zhen Tang, Zhong Lin, Rahul Krishna Reddy, Zhi Wei Zhang
  • Journal    : Urology Case Reports
  • Year         :2019

Burns injury characteristics and outcomes at lautoka hospital, fiji

      • Authors   : Rahul Krishna Reddy, Arun Murari, Akhtar Ali, Ronal Kumar, Livai Lutunaika, Abhay Choudhari, Swastika Devi, Famiza Kulsum
      • Journal    : Burns Open
      • Year         :2024

Characteristics and Outcomes of Acute Appendicitis in Lautoka Aspen Hospital, Fiji: An Observational Retrospective Study

  • Authors   : Rahul Krishna Reddy, M Arun, K Ronal, Akhtar Ali, Livai Lutunaika, Y Devi Chandra
  • Journal    : World J Surg Surgical Res
  • Year         :2024

Primary Epithelioid Hemangioendothelioma of the Kidney Pelvis

  • Authors   :Rahul Reddy
  • Journal     : American Journal of Surgery and Clinical Case Reports
  • Year         :2020                                                                                                                                                                                                                                                 

Dr. Michel Fares|Drug analysis|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Michel Fares|Drug analysis|Best Researcher Award

Dr. Michel Fares at Nahda University,Egypt

PROFILE  

scopus

Orcid

Google scholar

 

 

Early Academic Pursuits 📚

Michel Yousry Fares embarked on his academic journey with a strong foundation in pharmaceutical sciences, receiving his Bachelor of Pharmacy degree from Nahda University in Beni Suef, Egypt, in 2013. Graduating with honors and a high GPA of 3.89, he demonstrated an early commitment to excellence in his field. His passion for analytical chemistry led him to pursue a Master’s degree in Pharmaceutical Analytical Chemistry at Beni Suef University, where he further honed his skills and knowledge. In 2022, Michel earned his Ph.D. in Pharmaceutical Analytical Chemistry from Cairo University, solidifying his expertise in the analytical methods used to assess pharmaceutical compounds.

Professional Endeavors 🏫

Currently, Michel serves as a Lecturer in the Pharmaceutical Analytical Chemistry Department at Nahda University’s Faculty of Pharmacy, a position he has held since 2022. In this role, he teaches a variety of undergraduate courses, including Pharmaceutical Analytical Chemistry, Instrumental Analysis, and Quality Control of Pharmaceuticals. His responsibilities also extend to research activities in the field of analytical chemistry, where he contributes to advancing the understanding and application of various analytical techniques, such as chromatography and spectroscopy. Michel also plays a key role in mentoring and advising students, helping shape the future of aspiring pharmaceutical professionals.

Beyond his teaching responsibilities, Michel serves as the Vice President of Electronic Learning Support (ELS) at Nahda University, where he has been instrumental in developing and maintaining the university’s e-learning platform, Moodle. His efforts in training instructors and resolving technical issues have significantly enhanced the educational experience for both faculty and students at the university.

Contributions and Research Focus 🔬

Michel’s primary research interests lie in the field of pharmaceutical analytical chemistry, with a specific focus on drug analysis, bioanalysis, and the development of innovative analytical techniques. He has authored several research articles and reviews, including a prominent piece on miniaturized solid-phase extraction techniques for analyzing various pollutants. This work highlights his commitment to advancing analytical methods for environmental and pharmaceutical applications.

His research endeavors also extend to the study of pharmacokinetic parameters, quality assurance, and experimental design. By applying a range of analytical techniques, Michel contributes to improving the quality and safety of pharmaceutical products. His focus on practical applications of pharmaceutical analysis aims to bridge the gap between theoretical knowledge and real-world problem-solving in the pharmaceutical industry.

Accolades and Recognition 🏅

Michel’s contributions to both research and education have not gone unnoticed. He was honored with the “Best Research Publishing Record in the Teaching Assistant Category” in 2022 at Nahda University, a testament to his dedication to advancing scientific knowledge. In 2021, he received the “Best Scientific Research in the Field of Applied Pharmaceutical Sciences” award from ACDIMA (The Arab Company for Drug Industries and Medical Appliances), further cementing his reputation as a leading figure in his field.

Michel’s contributions extend beyond the classroom and laboratory, as he has been actively involved in organizing and participating in scientific conferences. Notably, he was a key participant in the 3rd International Conference of the Faculty of Pharmacy at Ain Shams University and the 2nd International Conference of Pharmaceutical & Therapeutical Science in 2023, where he presented on topics such as online education and creativity in analytical chemistry.

Impact and Influence 🌍

Through his work in both academia and research, Michel has had a profound impact on the field of pharmaceutical sciences. His innovative research has contributed to the development of more efficient and accurate analytical methods, particularly in drug analysis and bioanalysis. As a teacher, he has shaped the careers of many future pharmacists and analytical chemists, emphasizing the importance of precision and quality in pharmaceutical testing.

Michel’s influence extends beyond his direct teaching and research contributions. He has been a reviewer for several prestigious scientific journals, including TrAC Trends in Analytical Chemistry and Journal of Pharmaceutical and Biomedical Analysis, where his expertise helps shape the direction of future research in the field.

Legacy and Future Contributions 🌱

Michel’s legacy is one of dedication to the advancement of pharmaceutical sciences and the education of the next generation of professionals. His work in the development of analytical techniques has had a lasting impact on both the academic and pharmaceutical industries, and his commitment to improving the quality of education will continue to benefit students for years to come.

Looking forward, Michel plans to continue his research into novel analytical methods, with a focus on environmental applications and the use of cutting-edge technologies like electrochemistry and chromatography. His goal is to contribute to the development of sustainable practices within pharmaceutical analysis, ensuring that future generations of scientists have the tools they need to meet the evolving challenges of the global pharmaceutical industry.

In addition to his research, Michel is committed to furthering his role in educational leadership, particularly in the integration of digital technologies into the learning process. He envisions a future where e-learning systems are more widely adopted, creating a more accessible and flexible learning environment for students around the world.

Conclusion ✨

Michel Yousry Fares stands out as a dedicated educator, researcher, and leader in the field of pharmaceutical analytical chemistry. His career is characterized by his commitment to excellence in both teaching and research, his impact on the development of analytical methods, and his dedication to shaping the future of pharmaceutical sciences. Through his ongoing work, Michel will continue to leave a positive and lasting legacy in the field, inspiring future generations of scientists and educators.

🎓Publication 

Green analytical chemistry as an integral part of sustainable education development

  • Authors   : Justyna Płotka-Wasylka, Heba M Mohamed, Aleksandra Kurowska-Susdorf, Rajkumar Dewani, Michel Y Fares, Vasil Andruch
  • Journal    :Current Opinion in Green and Sustainable Chemistry
  • Year         :2021

Determination of the abused intravenously self-administered madness drops (Tropicamide) by liquid chromatography in rat plasma; an application to pharmacokinetic study and …

  • Authors   : Maha M Abdelrahman, Nada S Abdelwahab, Maha A Hegazy, Michel Y Fares, Ghada M EL-Sayed
  • Journal    : Microchemical Journal
  • Year         :2020

Determination of sofosbuvir with two co-administered drugs; paracetamol and DL-methionine by two chromatographic methods. Application to a pharmacokinetic study

  • Authors   :Michel Y Fares, Nada S Abdelwahab, Maha M Abdelrahman, Hamdy M Abdel-Rahman
  • Journal    : Bioanalysis
  • Year         :2019

Miniaturized solid phase extraction techniques for different kind of pollutants analysis: state of the art and future perspectives–PART 1

  • Authors   : Justyna Płotka-Wasylka, Natalia Jatkowska, Monika Paszkiewicz, Magda Caban, Michel Y Fares, Aysegul Dogan, Salvador Garrigues, Natalia Manousi, Natasa Kalogiouri, Paweł Mateusz Nowak, Victoria F Samanidou, Miguel de la Guardia
  • Journal    :TrAC Trends in Analytical Chemistry
  • Year         :2023

Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study

  • Authors   : Michel Y Fares, Maha A Hegazy, Ghada M El-Sayed, Maha M Abdelrahman, Nada S Abdelwahab
  • Journal    :RSC advances
  • Year         :2022

Mr. Yeniewa Anagaw| Pharmacy|Best Researcher Award

Published on by Top Pharmaceutical

Mr. Yeniewa Anagaw| Pharmaceutical Pharmacy
|Best Researcher Award

Mr. Yeniewa Anagaw at Medical University of Gondar,Ethiopia

PROFILE  

scopus

Google scholar

Early Academic Pursuits 📚

Yeniewa Kerie Anagaw’s journey in academia began with his Bachelor of Pharmacy degree from Miza-Tepi University, Ethiopia, in 2016. Graduating with a commendable cGPA of 3.39/4.00, his directed study explored a critical area of public health, specifically focusing on tuberculosis treatment outcomes and predictors among HIV patients in Southwest Ethiopia. This early research demonstrated his keen interest in addressing significant health challenges affecting his community. He continued his academic growth with a Master of Science in Pharmaceutical Analysis and Quality Assurance at Addis Ababa University, where he earned an impressive cGPA of 3.81/4.00. His thesis, titled “Analytical Method Development and Validation Based on Paper Analytical Device (PAD) for Adulteration Detection in Teff Injera (Ethiopian flatbread),” highlights his dedication to innovation in pharmaceutical analysis and public health. This work, which employed Microwave Plasma Atomic Emission Spectroscopy (MP-AES), underscores his analytical and scientific rigor.

Professional Endeavors and Teaching Commitments 👨‍🏫

Yeniewa’s professional career took off in December 2016 when he joined Finote Selam General Hospital as a junior pharmacist. In this role, he participated in ward rounds and patient chart reviews, where he helped identify, prevent, and mitigate drug-related problems. His responsibilities included ensuring appropriate drug selection and dosage, managing adverse drug reactions, addressing drug interactions, and preparing compounded dermatological formulations. Yeniewa also worked as a pharmacy coordinator, showcasing his leadership and organizational skills early in his career.

By January 2018, Yeniewa transitioned into academia as an assistant lecturer at the University of Gondar’s School of Pharmacy. In this role, he supervised and instructed undergraduate students in Pharmaceutical Analysis laboratory sessions, focusing on hands-on training in instrumental analysis and data interpretation. His role expanded to delivering lectures in Pharmaceutical Analysis, Pharmacy Practice, and Quality Control and Assurance. Yeniewa’s dynamic teaching style, coupled with his passion for research, has made him a pivotal figure in shaping future pharmacists.

Since April 2022, Yeniewa has held a lecturer position at the University of Gondar. Here, his responsibilities have evolved to include not only lecture preparation and delivery but also student mentoring, exam evaluation, and practical learning experiences. Yeniewa’s teaching covers Electroanalytical Methods, IR Spectroscopy, NMR, HPLC, and Mass Spectrometry (MS), which are crucial tools in the field of pharmaceutical science. His ability to guide students through both theoretical and practical knowledge demonstrates his comprehensive approach to education.

Contributions and Research Focus 🔬

Yeniewa’s research interests span across various domains within pharmaceutical sciences, including pharmaceutical analysis, quality assurance, proteomics, metabolomics, drug delivery, and biomarker discovery. His dedication to research is reflected in his published works and his involvement in grant writing for school projects. Yeniewa is particularly passionate about developing analytical methods for drug adulteration detection, exemplified by his thesis on detecting adulterants in Teff Injera. This research is crucial for ensuring food safety and protecting public health.

Additionally, Yeniewa has participated in several community service initiatives. One notable contribution involved the quantitative analysis of table salt used for wound cleaning, showcasing his commitment to improving healthcare practices in Ethiopia. His engagement in such community-oriented projects demonstrates his desire to translate academic research into practical solutions that benefit society.

Accolades and Recognition 🏅

Throughout his career, Yeniewa has earned various certificates and recognition for his contributions to both academia and the pharmaceutical field. Some of his notable achievements include:

  • Certificate of the training workshop on “Anticancer Medicines Quality Evaluation Using the Chemo-spot System.”
  • BMJ Open Reviewer’s Certificate and Peer Reviewer Verification Certificates from Springer Nature, which highlight his contributions to scientific literature through peer review.
  • Presenter Certificate at the “42nd Annual Scientific Conference of the Ethiopia Pharmacy Association (EPA),” where he shared his research with a broader scientific community.
  • Certificates for attending workshops and training sessions on research enhancement, intellectual property, and good manufacturing practices (GMP), indicating his commitment to continuous professional development.

Impact and Influence 🌍

Yeniewa’s influence extends beyond his immediate academic and professional circles. His research on tuberculosis treatment and pharmaceutical adulteration contributes to public health advancements, particularly in Ethiopia. By addressing key issues in drug safety and treatment optimization, he has played a role in enhancing healthcare outcomes for vulnerable populations. As a lecturer, Yeniewa has directly impacted the education of future pharmacists, providing them with the knowledge and skills necessary to excel in both clinical and research settings. His involvement in grant writing and school projects also demonstrates his efforts to foster research initiatives that could have far-reaching benefits.

Legacy and Future Contributions 🌟

As Yeniewa continues his career, his focus remains on bridging the gap between pharmaceutical research and practical healthcare solutions. His expertise in proteomics, drug discovery, and spectroscopic methods positions him as a valuable contributor to ongoing efforts in pharmaceutical innovation. Furthermore, his dedication to teaching ensures that future generations of pharmacists are well-equipped to tackle emerging challenges in the field.

Yeniewa’s future contributions are likely to leave a lasting legacy, both in terms of academic excellence and practical healthcare improvements. His adaptability, hard work, and passion for both teaching and research will continue to drive his success as he navigates the evolving landscape of pharmaceutical sciences.

🎓Publication 

Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia

  • Authors   :Adane Teshome Kefale, Yeniewa Kerie Anagaw
  • Journal    :International Journal of General Medicine
  • Year         :2017

Assessment of community pharmacy professionals’ willingness, involvement, beliefs, and barriers to offer health promotion services: a cross-sectional study

  • Authors   : Wondim Ayenew, Abdulwase Mohammed Seid, Asmamaw Emagn Kasahun, Asrat Elias Ergena, Derso Teju Geremaw, Liknaw Workie Limenh, Teshome Bitew Demelash, Wudneh Simegn, Yeniewa Kerie Anagaw, L.
  • Journal    :BMC Health Services Research
  • Year         :2022

Assessment of Knowledge, Attitudes, and Practices of Traditional Healers toward Dosage Forms and Routes of Administration: A Cross‐Sectional Study in Ethiopia

  • Authors   : Liknaw Workie Limenh, Derso Teju Geremew, Asmamaw Emagn Kasahun, Yeniewa Kerie Anagaw, Minichil Chanie Worku, Wudneh Simegn, Wondim Ayenew
  • Journal    :Evidence‐Based Complementary and Alternative Medicine
  • Year         :2023

Assessment of knowledge, attitude, and practice on substandard and counterfeit pharmaceutical products among pharmacy professionals in Gondar City, North-West Ethiopia

  • Authors   :Minichil Chanie Worku, Melese Legesse Mitku, Wondm Ayenew, Liknew Workie Limenh, Asrat Elias Ergena, Derso Teju Geremew, Gizachew Kassahun Bizuneh, Bereket Bahiru Tefera, Biset Asrade Mekonnen, Yeniewa Kerie Anagaw
  • Journal    :Currents in Pharmacy Teaching and Learning
  • Year         :2024

Prevalence and predictors of self-medication with antibiotics in Ethiopia: a systematic review and meta-analysis

  • Authors   :Wondim Ayenew, Tewodros Ayalew Tessema, Yeniewa Kerie Anagaw, Ebrahim Abdela Siraj, Segenet Zewdie, Wudneh Simegn, Liknaw Workie Limenh, Chernet Tafere, Ashagrachew Tewabe Yayehrad
  • Journal    :Antimicrobial Resistance & Infection Control
  • Year         :2024